New antibody drug tested in fight against sudden, severe lung failure
Disease control
Ongoing
This study is testing a new antibody drug called ALT-100 in hospitalized adults with moderate to severe Acute Respiratory Distress Syndrome (ARDS), a life-threatening form of lung failure. The main goals are to see if the drug is safe and if it can help patients breathe without a…
Phase: PHASE2 • Sponsor: Aqualung Therapeutics Corp. • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC